Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Pelvic Neoplasms 1Ovarian Neoplasms 1Low Anterior Resection Syndrome 1Anus Neoplasms 1

Interventions

Fluorouracil 14Radiotherapy 11Mitomycin 9Radiation 8Capecitabine 8Surveys and Questionnaires 6Drug Therapy 6Cisplatin 6pembrolizumab 5Paclitaxel 4Magnetic Resonance Spectroscopy 4Irinotecan 3Immune Checkpoint Inhibitors 3Cetuximab 3Carboplatin 3Biopsy 3tislelizumab 2durvalumab 2atezolizumab 2aldesleukin 2Therapeutics 2Specimen Handling 2Papillomavirus Vaccines 2Oxaliplatin 2Observation 2Nivolumab 2Cyclophosphamide 2Blood Specimen Collection 2Adoptive Transfer 2toripalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anus Neoplasms × Device Removal × Clear all
NCT04066894 2023-08-14

Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study

M.D. Anderson Cancer Center

Phase 2 Terminated
3 enrolled 5 charts
GastrointestinalGenitourinaryGynecologic

Low Anterior Resection Syndrome, Anus Neoplasms, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Pelvic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡